Partial response to crizotinib + regorafenib + PD-1 inhibitor in a metastatic BRAF V600EMT colon cancer patient with acquired C-MET amplification and TPM4-ALK fusion: a case report
@article{ACR9097,
author = {Yingying Huang and Shuai Zhang and Xueqing Hu and Xiangyang Wang and Yunbo Zhao and Zhongkang Li},
title = {Partial response to crizotinib + regorafenib + PD-1 inhibitor in a metastatic BRAF V600EMT colon cancer patient with acquired C-MET amplification and TPM4-ALK fusion: a case report},
journal = {AME Case Reports},
volume = {8},
number = {0},
year = {2024},
keywords = {},
abstract = {},
issn = {2523-1995}, url = {https://acr.amegroups.org/article/view/9097}
}